(Total Views: 490)
Posted On: 03/10/2021 7:22:27 AM
Post# of 155790
My concern for months on hiv BLA has been what if fda is requiring receptor occupancy data and there’s no way to obtain it anymore? Is that possibly why np won’t discuss the BLA? Any possibility we’ll have to redo the whole trial?
(0)
(0)
